Despite the current conclusion that AFP threshold of 400 ng/mL should be used for the diagnosis of HCC, the threshold of 20 ng/mL should also be suggested to lead to the decision to let a patient go into the surveillance program for HCC due to its high sensitivity. The gene discussed is AFP; the disease is hepatocellular carcinoma.